CSL Ltd
update 02:10
59.69
-1.17 (-1.92%%)
TODAY
High 61.60
Low 59.19
Open 61.59
Volume 1673568
Time 02:10
52 WEEK SUMMARY
High 64.70
Low 36.54
P/E 25.67
Return
57.91%
Mkt Cap
29.354 B
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=438123991&utmp=%2Fquote%2FCSL%3AAU%3Fticker%3DCSL%3AAU%26count%3D5&utmhn=10.248.67.17&utmac=UA-11413116-12&utmhid=850888637)